John P. de Koning - Concepedia

Author

John P. de Koning

Erasmus University Rotterdam

Also Known As

J P de Koning, John P De Koning, John P de Koning, John P. De Koning, John P. de Koning

Publications

Citations

H-Index

Concepts

All Affiliations

Erasmus University Rotterdam UCSF Helen Diller Family Comprehensive Cancer Center University of California, San Francisco Rotterdam University of Applied Sciences Roswell Park Comprehensive Cancer Center

About

John P. de Koning is an author at Erasmus University Rotterdam specializing in medicine, cell biology, and cancer genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	519
2	Cell Biology	3	3	506
3	Pathology	3	3	393
4	Immunology	1	1	126
5	Cancer Cell Biology	1	1	60

John P. de Koning

Publications

929

Citations

H-Index

Page 1

	Year	Citations
Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human Amanda E. Toland, Paraskevi Briassouli, John P. de Koning, Nature Genetics OncologyMedicinePathologyCancer GenomicsCancer Biology	2003	320
STAT3-mediated differentiation and survival of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27Kip1 John P. de Koning, Amrita A. Soede-Bobok, Alister C. Ward, Oncogene InflammationCytokineHematological MalignancyGranulocyteImmunology	2000	126
Multiple Signals Mediate Proliferation, Differentiation, and Survival from the Granulocyte Colony-stimulating Factor Receptor in Myeloid 32D Cells Alister C. Ward, Louise Smith, John P. de Koning, Journal of Biological Chemistry	1999	123
Stimulation of Stat5 by Granulocyte Colony-Stimulating Factor (G-CSF) Is Modulated by Two Distinct Cytoplasmic Regions of the G-CSF Receptor Fan Dong, Xiuwen Liu, John P. de Koning, The Journal of Immunology	1998	95
Novel Point Mutation in the Extracellular Domain of the Granulocyte Colony-Stimulating Factor (G-Csf) Receptor in a Case of Severe Congenital Neutropenia Hyporesponsive to G-Csf Treatment Alister C. Ward, Yvette M. van Aesch, Judith Gits, The Journal of Experimental Medicine	1999	86
Proliferation Signaling and Activation of Shc, p21Ras, and Myc Via Tyrosine 764 of Human Granulocyte Colony-Stimulating Factor Receptor John P. de Koning, Amrita A. Soede-Bobok, Anita M. Schelen, Blood	1998	65
Epistatic interactions between skin tumor modifier loci in interspecific (spretus/musculus) backcross mice. Hiroki Nagase, Jian‐Hua Mao, John P. de Koning, PubMed GeneticsPathologyGene CharacterizationGenomicsDermatology	2001	60
Genetic variants of<i>Tgfb1</i>act as context-dependent modifiers of mouse skin tumor susceptibility Jian‐Hua Mao, Elise F. Saunier, John P. de Koning, Proceedings of the National Academy of Sciences	2006	41
Convergence of congenic mapping and allele-specific alterations in tumors for the resolution of the Skts1 skin tumor susceptibility locus John P. de Koning, Yuichi Wakabayashi, Hiroki Nagase, Oncogene Tumor BiologyCongenic MappingSomatic VariantPathologyCancer Genomics	2007	13

Page 1